SHOULD CLINICIAN BE CONCERNED ABOUT THE CARCINOGENIC POTENTIAL OF TAMOXIFEN

被引：58

作者：

JORDAN, VC ^{[1
]}

MORROW, M ^{[1
]}

机构：

[1] NORTHWESTERN UNIV,SCH MED,DEPT SURG,CHICAGO,IL 60611

来源：

EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 11期

关键词：

D O I：

10.1016/0959-8049(94)00349-A

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1714 / 1721

页数：8

共 48 条

[1]

[Anonymous], 1990, HLTH EFFECTS EXPOSUR

[2]

BORONOW RC, 1984, OBSTET GYNECOL, V63, P825

[3] ENDOMETRIAL HYPERPLASIA IN AN OOPHORECTOMIZED WOMAN RECEIVING TAMOXIFEN THERAPY - CASE-REPORT [J].

CROSS, SS ;

ISMAIL, SM .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (02) :190-192

[4]

DEGREGORIO MW, 1992, J NIH RES, V4, P84

[5] ENDOMETRIAL LESIONS IN PATIENTS UNDERGOING TAMOXIFEN THERAPY [J].

DEMUYLDER, X ;

NEVEN, P ;

DESOMER, M ;

VANBELLE, Y ;

VANDERICK, G ;

DEMUYLDER, E .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1991, 36 (02) :127-130

[6] STUDIES OF TAMOXIFEN AS A PROMOTER OF HEPATOCARCINOGENESIS IN FEMALE FISCHER F344 RATS [J].

DRAGAN, YP ;

FAHEY, S ;

STREET, K ;

VAUGHAN, J ;

JORDAN, VC ;

PITOT, HC .

BREAST CANCER RESEARCH AND TREATMENT, 1994, 31 (01) :11-25

[7] ADJUVANT TRIAL OF 12 CYCLES OF CMFPT FOLLOWED BY OBSERVATION OR CONTINUOUS TAMOXIFEN VERSUS 4 CYCLES OF CMFPT IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER - AN EASTERN COOPERATIVE ONCOLOGY GROUP PHASE-III STUDY [J].

FALKSON, HC ;

GRAY, R ;

WOLBERG, WH ;

GILLCHRIST, KW ;

HARRIS, JE ;

TORMEY, DC ;

FALKSON, G .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :599-607

[8] ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14 [J].

FISHER, B ;

COSTANTINO, JP ;

REDMOND, CK ;

FISHER, ER ;

WICKERHAM, DL ;

CRONIN, WM ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

EVANS, J ;

FARRAR, W ;

KAVANAH, M ;

LICKLEY, HL ;

MARGOLESE, R ;

PATERSON, AHG ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) :527-537

[9]

FISHER B, 1991, CLIN TRIAL DETERMINE

[10] DESCRIPTIVE CLINICOPATHOLOGICAL STUDY OF 17 PATIENTS WITH ENDOMETRIAL CANCER DURING OR AFTER ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER [J].

FORNANDER, T ;

HELLSTROM, AC ;

MOBERGER, B .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (22) :1850-1855

← 1 2 3 4 5 →